Asthma & Allergies: The Allergic Airway

Written by Empire Medical Training Editorial Team

Medically reviewed by Sherry Wehner, MD Board-Certified Pathologist & Dermatopathologist; Aesthetic & Wellness Medicine

Updated June 2026 ·10 min read

For most patients, allergies and asthma travel together. The runny nose and itchy eyes of hay fever and the wheeze and chest tightness of asthma can look like separate conditions, but in allergic (atopic) asthma they share one engine: an IgE-mediated immune response to inhaled allergens. Understanding that shared mechanism is what lets a clinician connect a patient's nasal symptoms, their skin-test results, and their breathing into a single coherent picture — and know exactly where allergy care helps and where it must defer to dedicated asthma management.

This guide sits within Empire's broader resource on allergy testing and treatment and is written for clinicians. It is clinical education, not medical advice, and nothing here is a treatment protocol or a substitute for current guidelines and individualized care.

What asthma actually is

Asthma is a chronic inflammatory condition of the airways. As Dr. Sherry Wehner frames it in Empire's allergy course, it is defined by three hallmark characteristics: reversible airway obstruction, bronchial hyper-responsiveness, and chronic inflammation. Roughly 5 to 10 percent of Americans live with it, so it is something nearly every practice will encounter. Like most disease, its development is multifactorial — genetics, environment, and immunology all contribute — which is the same triad that drives allergic disease in general.

The practical meaning of those three characteristics is worth slowing down on. Chronic inflammation keeps the airway lining swollen and twitchy even between flares. That underlying state is what produces bronchial hyper-responsiveness: airways that overreact to stimuli a healthy lung would ignore. And when a trigger lands, the smooth muscle wrapping the airways constricts, mucus increases, and the lumen narrows — the reversible obstruction a patient experiences as wheeze, cough, chest tightness, and breathlessness. The word reversible is the hopeful part: with the right management, that obstruction can open back up.

Allergic (atopic) asthma and the shared mechanism

Not all asthma is allergic, but a large share of it is. In allergic asthma, the triggers that set off an attack are the same inhaled allergens that drive nasal allergy: dust mites, pet dander, mold and fungal spores, pollens from grasses and trees. Wehner's course lists exactly these as the biological factors most likely to provoke an asthmatic patient — pets, pests, pollen, fungus — alongside non-allergic contributors such as viruses, tobacco smoke, and air pollution.

The reason an allergen in the nose and an allergen in the lung produce related trouble is that the underlying immune cascade is identical. When a sensitized patient inhales an allergen, it binds IgE antibodies sitting on mast cells. That binding triggers degranulation and the release of mediators — most importantly histamine, along with prostaglandins, tryptase, and others. In the nose those mediators cause congestion and itch; in the lower airways the same chemistry produces inflammation, mucus, and bronchoconstriction. Same antibody, same mast cell, same mediators — a different floor of the same house. That is why thinking of allergic asthma as the lower-airway expression of an allergic patient's atopy is more accurate than treating it as a wholly separate diagnosis.

One airway, one disease

The nose and the lungs are not two organs that happen to be near each other — they are one continuous respiratory tract lined by related mucosa and exposed to the same inhaled air. This is the basis of the "one airway, one disease" framing that links allergic rhinitis and asthma so tightly. A patient whose upper airway is allergically inflamed very often has lower-airway inflammation too, even when the chest symptoms are quieter than the nasal ones.

The clinical payoff is concrete: when you take a thorough allergy history, the nasal and ocular symptoms a patient volunteers are also clues about their lower airway. A long history of allergic rhinitis, seasonal flares that track with pollen counts, and a home full of dust-mite or pet exposure all raise the index of suspicion for an allergic component to a patient's wheeze. It also means that controlling allergic rhinitis is not cosmetic — better upper-airway control is part of a coherent strategy for the airway as a whole, working alongside, not instead of, dedicated asthma treatment.

The atopic (allergic) march

Allergic disease tends to unfold in a recognizable order over a lifetime, a progression clinicians call the atopic march (or allergic march). The classic sequence begins in infancy with eczema and food allergy, moves into allergic rhinitis in early childhood, and in a subset of patients arrives at asthma. It is a pattern and a probability, not a fixed track every child follows — but it is clinically powerful, because it tells you that a toddler with stubborn eczema or a child with persistent hay fever carries elevated risk of developing asthma down the line.

This is also where genetics earns its weight. As Wehner notes, a child with one allergic parent is roughly 30 to 50 percent more likely to develop allergies, and with two allergic parents that climbs to 60 to 80 percent. Family history of atopy is therefore not a footnote on the intake form — it is a meaningful predictor that should sharpen how attentively you screen a young patient's respiratory and skin symptoms over time.

How allergens trigger an asthma attack

An asthma flare in an allergic patient is the visible end of an invisible cascade. Wehner's course catalogs the factors that contribute to an attack, and they sort into useful buckets:

• Biological triggers — the allergic ones (dust mites, pet dander, mold, pollen) plus infectious ones (viruses, bacteria) and pests such as cockroaches.
• Chemical triggers — tobacco smoke, combustion products, and pesticides.
• Structural and environmental factors — water damage, moisture, and deteriorated buildings that foster mold and dust-mite growth.
• Social and physiologic factors — stress and other stressors that lower the threshold for symptoms.

For the allergic subset, the sequence is the one described above: the inhaled allergen meets IgE on airway mast cells, mediators pour out, and the airway responds with inflammation and bronchoconstriction. Because the patient's airways are already hyper-responsive from chronic inflammation, it takes less provocation to tip them into obstruction than it would in a healthy lung — which is exactly why identifying and reducing those allergic triggers can meaningfully lower how often the airway is provoked.

Where allergy testing fits

If allergens are driving the airway, then naming the allergens is genuinely useful — not as a fishing expedition, but as a way to guide targeted avoidance and to decide whether immunotherapy is appropriate. When you evaluate a patient with an allergic airway, the workup mirrors any allergy evaluation: a thorough history first, then objective testing. The skin-prick test is the cheap, quick, visible first-line tool, and specific-IgE blood testing is the alternative when skin testing is unsuitable. Both confirm sensitization to specific environmental allergens — dust mites, pet dander, molds, pollens — so avoidance and treatment can be aimed at the right targets.

Two honest caveats matter here. First, a positive test confirms sensitization, not causation — results only mean something when correlated with the patient's actual clinical history, so neither test stands alone. Second, and more important for this topic: skin testing carries a safety line where asthma is concerned. Wehner is explicit that uncontrolled asthma is a contraindication to skin-prick testing and that such a patient should be referred to a board-certified immunologist rather than tested in a general practice. The same goes for a history of anaphylaxis. And whenever skin testing is performed, emergency preparedness is non-negotiable: epinephrine on hand, because anaphylaxis is a medical emergency whose first-line treatment is intramuscular epinephrine.

Where immunotherapy fits — and its limits

For the right patient, allergy immunotherapy is the one allergy treatment that can change the underlying disease rather than just blunt symptoms. Subcutaneous immunotherapy (SCIT, "allergy shots") is the well-established, disease-modifying option, and it works specifically for environmental allergens — the very triggers behind allergic asthma. It is not used for food or contact allergies; for those, avoidance is the tool. Sublingual immunotherapy (SLIT) is more convenient because patients dose at home, and FDA-approved SLIT tablets exist for specific allergens such as grass, ragweed, and dust mite; compounded "allergy drops," by contrast, are largely off-label, and as Wehner notes are generally less effective and not covered by insurance.

Here the safety framing has to lead. Immunotherapy in an asthmatic patient is an area that rewards caution and patient selection. Patients with severe or uncontrolled asthma carry higher risk from allergen immunotherapy and are appropriately referred to a board-certified allergist or immunologist rather than managed in a general practice. Even in well-selected patients, shots are given where emergency care is available, patients are observed afterward for systemic reactions, and a stepwise build-up is followed. Most fundamentally: immunotherapy is an adjunct to asthma management, not a substitute for it. The controller inhaler, the rescue inhaler, and the action plan stay in place; immunotherapy works on the allergic driver underneath them.

Knowing your scope: when to refer

The honest center of this whole topic is a boundary. Allergy testing and immunotherapy let a trained clinician address the allergic contribution to an allergic airway — identifying triggers, guiding avoidance, and, in appropriate cases, offering desensitization. They do not manage asthma itself, which remains a serious condition requiring controller and rescue therapy, monitoring, and a clear plan for exacerbations.

Wehner's own practice draws this line plainly: asthma is not the focus of allergy testing, and asthmatic patients are typically more complicated and are referred to a board-certified immunologist. The clear referral triggers to internalize are severe or uncontrolled asthma, a history of anaphylaxis, and any systemic reaction — each of which moves a patient out of routine allergy care and toward specialist management. Testing and treating allergy responsibly means knowing precisely where your scope ends, and building the emergency readiness and referral relationships that make that boundary safe. Empire's course teaches exactly that judgment, alongside the science.